Possibilities of improving the effectiveness of treatment of manifestations of metabolic syndrome in the elderly (on the example of taurine)

Author:

Golovanova E. V.1

Affiliation:

1. Moscow State University of Medicine and Density n. a. A. I. Evdokimov

Abstract

The article presents modern data on the formation and manifestations of multiple metabolic disorders with an emphasis on the features of pathology in old age. Age-related changes in nutrition, physical activity, carbohydrate and lipid metabolism are additional risk factors for the development of metabolic syndrome and determine the high prevalence of this pathology in old age. Multiple metabolic disorders aggravate the course of each of them and worsen the prognosis due to high risks of cardiovascular and other types of mortality. Timely diagnosis and effective correction of metabolic syndrome manifestations will reduce these risks and increase life expectancy while improving its quality. In order to increase the effectiveness of basic therapy of metabolic disorders, the use of drugs capable of positively affecting multiple metabolic disorders has been shown. In particular, this paper provides an evidence base for the effectiveness of taurine in patients with metabolic syndrome. When using taurine in addition to basic standard therapy, there is a significant decrease in blood pressure, glucose levels, insulin, serum lipid spectrum, body mass index.

Publisher

LLC Global Media Technology

Subject

Gastroenterology,Hepatology

Reference39 articles.

1. Clinical guidelines for the diagnosis and treatment of metabolic syndrome, Available: https://mzdrav.rk.gov.ru/file/mzdrav18042014_Klinicheskie_rekomendaciiMetabolicheskij sindrom.pdf, (2013), Access: 07/02/2021.@@ Klinicheskie rekomendatsii po diagnostike i lecheniyu metabolicheskogo sindroma, https://mzdrav.rk.gov.ru/file/mzdrav18042014_Klinicheskie_rekomendaciiMetabolicheskij sindrom.pdf, (2013), obrashchenie ot 02.07.2021.

2. Mychka V.B., Vertkin A. L., Vardaev L. I., et al. Experts’ consensus on the interdisciplinary approach towards the management, diagnostics, and treatment of patients with metabolic syndrome. Cardiovascular Therapy and Prevention. 2013;12(6):41-82. (In Russ.)@@ Mychka V. B., Vertkin A. L., Vardaev L. I. i soavt. Konsensus ekspertov po mezhdistsiplinarnomu podkhodu k vedeniyu, diagnostike i lecheniyu bol'nykh s metabolicheskim sindromom. Kardiovaskulyarnaya terapiya i profilaktika. 2013;12(6):41-82.

3. Eslam M., Newsome P. N., Sarin S. K., et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039

4. Eslam M., Sanyal A. J., George J.; International Consensus Panel. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology. 2020;158(7):1999-2014.e1. doi:10.1053/j.gastro.2019.11.312.

5. Angulo P, Kleiner DE, Dam-Larsen S et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes patients with nonalcoholic fatty liver disease. Gastroenterology. 2015 Aug;149(2):389-97.e10. doi: 10.1053/j.gastro.2015.04.043.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3